Peyronie's disease (PD) is a wound-healing disorder often characterized by the triad of penile pain, curvature, and sexual dysfunction at initial presentation.
1 Gur S Limin M Hellstrom WJG. Current status and new developments in Peyronie’s disease: Medical, minimally invasive and surgical treatment options.
Expert Opin Pharmacother. 2011; 12 : 931-944 Crossref PubMed Scopus (52) Google Scholar
Peyronie's plaque pathogenesis remains incompletely elucidated but is thought to arise from abnormal extracellular matrix production. Studies suggest that PD prevalence is as high as 9% in the general population and higher in patients with diabetes or after radical prostatectomy.
2 Herati AS Pastuszak AW. The genetic basis of Peyronie disease: A review.
Sex Med Rev. 2016; 4 : 85-94 Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar
A broad spectrum of treatments for PD are available including: surveillance, traction devices, intralesional injections and surgical interventions.
3 Salonia A Bettocchi C Boeri L et al. European Association of Urology guidelines on sexual and reproductive health—2021 update: Male sexual dysfunction [Formula presented].
Eur Urol. 2021; 80 : 333-357 Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar
There is an ever-growing interest in practical, low cost, state-of-the-art, minimally invasive approaches to manage this common problem.